drugset / Trial / NCT03807245
Group B Streptococcus Vaccine in Healthy Females
RandomizedParallel-groupTriple-blindTreatment
Summary
A Phase I, randomised, single centre, double-blind, placebo-controlled, parallel group study to evaluate the safety, tolerability and immunogenicity of two doses of Group B Streptococcus vaccine.
Timeline
- Start
- 2019-01-09
- Primary completion
- 2019-10-14
- Completion
- 2020-05-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GBS-NN/NN2 | Vaccine | 25 ug | Intramuscular |
| Subject | GBS-NN/NN2 | Vaccine | 50 ug | Intramuscular |